128 related articles for article (PubMed ID: 9641002)
21. An open trial of fluvoxamine therapy for panic disorder complicated by depression.
Spiegel DA; Saeed SA; Bruce TJ
J Clin Psychiatry; 1996; 57 Suppl 8():37-40; discussion 40-1. PubMed ID: 8698679
[TBL] [Abstract][Full Text] [Related]
22. Venlafaxine versus nortriptyline in the treatment of elderly depressed inpatients: a randomised, double-blind, controlled trial.
Kok RM; Nolen WA; Heeren TJ
Int J Geriatr Psychiatry; 2007 Dec; 22(12):1247-54. PubMed ID: 17562523
[TBL] [Abstract][Full Text] [Related]
23. Venlafaxine extended release (XR) in the treatment of generalized anxiety disorder.
Sheehan DV
J Clin Psychiatry; 1999; 60 Suppl 22():23-8. PubMed ID: 10634352
[TBL] [Abstract][Full Text] [Related]
24. Venlafaxine in the treatment of depressive and vasomotor symptoms in women with perimenopausal depression.
Ladd CO; Newport DJ; Ragan KA; Loughhead A; Stowe ZN
Depress Anxiety; 2005; 22(2):94-7. PubMed ID: 16094663
[TBL] [Abstract][Full Text] [Related]
25. Effects of venlafaxine extended release on resilience in posttraumatic stress disorder: an item analysis of the Connor-Davidson Resilience Scale.
Davidson J; Baldwin DS; Stein DJ; Pedersen R; Ahmed S; Musgnung J; Benattia I; Rothbaum BO
Int Clin Psychopharmacol; 2008 Sep; 23(5):299-303. PubMed ID: 18703940
[TBL] [Abstract][Full Text] [Related]
26. Venlafaxine in dysthymic disorder.
Dunner DL; Hendrickson HE; Bea C; Budech CB
J Clin Psychiatry; 1997 Dec; 58(12):528-31. PubMed ID: 9448655
[TBL] [Abstract][Full Text] [Related]
27. Effect of the antidepressant venlafaxine in functional dyspepsia: a randomized, double-blind, placebo-controlled trial.
van Kerkhoven LA; Laheij RJ; Aparicio N; De Boer WA; Van den Hazel S; Tan AC; Witteman BJ; Jansen JB
Clin Gastroenterol Hepatol; 2008 Jul; 6(7):746-52; quiz 718. PubMed ID: 18424191
[TBL] [Abstract][Full Text] [Related]
28. Attaining remission in generalized anxiety disorder: venlafaxine extended release comparative data.
Sheehan DV
J Clin Psychiatry; 2001; 62 Suppl 19():26-31. PubMed ID: 11577788
[TBL] [Abstract][Full Text] [Related]
29. Venlafaxine: loss of antidepressant effect and its management.
Sharma V
J Clin Psychiatry; 1998 Jul; 59(7):381-2. PubMed ID: 9714268
[No Abstract] [Full Text] [Related]
30. An open clinical trial of venlafaxine treatment of fibromyalgia.
Dwight MM; Arnold LM; O'Brien H; Metzger R; Morris-Park E; Keck PE
Psychosomatics; 1998; 39(1):14-7. PubMed ID: 9538670
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of open-label venlafaxine in subjects with major depressive disorder: associations with neuroendocrine response to serotonergic and noradrenergic probes.
Grossman R; Reynolds D; Goodman M; New A; Silverman J; Schmeidler J; Mitropoulou V; Siever LJ
Psychiatry Res; 2004 Sep; 128(2):203-6. PubMed ID: 15488964
[TBL] [Abstract][Full Text] [Related]
32. Venlafaxine in depressed geriatric outpatients: an open-label clinical study.
Khan A; Rudolph R; Baumel B; Ferguson J; Ryan P; Shrivastava R
Psychopharmacol Bull; 1995; 31(4):753-8. PubMed ID: 8851649
[TBL] [Abstract][Full Text] [Related]
33. A double-blind comparison between bupropion XL and venlafaxine XR: sexual functioning, antidepressant efficacy, and tolerability.
Thase ME; Clayton AH; Haight BR; Thompson AH; Modell JG; Johnston JA
J Clin Psychopharmacol; 2006 Oct; 26(5):482-8. PubMed ID: 16974189
[TBL] [Abstract][Full Text] [Related]
34. The use of low-dose intranasal midazolam to treat panic disorder: a pilot study.
Schweizer E; Clary C; Dever AI; Mandos LA
J Clin Psychiatry; 1992 Jan; 53(1):19-22. PubMed ID: 1737735
[TBL] [Abstract][Full Text] [Related]
35. The effect of one-week treatment with venlafaxine on 35% CO2 hyperreactivity in patients with panic disorder: an open study.
Bertani A; Bellodi L; Bussi R; Caldirola D; Cucchi M; Perna G
J Clin Psychopharmacol; 2003 Feb; 23(1):106-8. PubMed ID: 12544387
[No Abstract] [Full Text] [Related]
36. Venlafaxine in the treatment of borderline personality disorder.
Markovitz PJ; Wagner SC
Psychopharmacol Bull; 1995; 31(4):773-7. PubMed ID: 8851652
[TBL] [Abstract][Full Text] [Related]
37. Methodologies and outcomes from the sertraline multicenter flexible-dose trials.
Rapaport MH; Wolkow RM; Clary CM
Psychopharmacol Bull; 1998; 34(2):183-9. PubMed ID: 9640998
[TBL] [Abstract][Full Text] [Related]
38. Relapse prevention of panic disorder in adult outpatient responders to treatment with venlafaxine extended release.
Ferguson JM; Khan A; Mangano R; Entsuah R; Tzanis E
J Clin Psychiatry; 2007 Jan; 68(1):58-68. PubMed ID: 17284131
[TBL] [Abstract][Full Text] [Related]
39. Venlafaxine treatment of panic disorder: a case series.
Geracioti TD
J Clin Psychiatry; 1995 Sep; 56(9):408-10. PubMed ID: 7665539
[TBL] [Abstract][Full Text] [Related]
40. Venlafaxine withdrawal syndrome.
Sabljić V; Ružić K; Rakun R
Psychiatr Danub; 2011 Mar; 23(1):117-9. PubMed ID: 21448114
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
